Paco E. Bravo, MD
Assistant Professor of Radiology at the Hospital of the University of Pennsylvania
Active Physician, Penn Presbyterian Medical Center - Department of Radiology
Active Physician, Pennsylvania Hospital - Department of Radiology
Active Physician, Hospital of the University of Pennsylvania - Department of Radiology
Director of Nuclear Cardiology, University of Pennsylvania
Vice-Chair for the Radiation Research Safety Committee (RRSC), University of Pennsylvania
Chair for Nuclear Cardiology Governance, University of Pennsylvania Health System
Co-Director of the Cardiovascular Phenotyping Unit, Center for Human Phenomic Science (CHPS), University of Pennsylvania
Department: Radiology
Contact information
Hospital of University of Pennsylvania
Department of Radiology
1 Silverstein
3400 Spruce Street
Philadelphia, PA 19104
Department of Radiology
1 Silverstein
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-220-9494
Publications
Links
Search PubMed for articles
Penn Nuclear Medicine
Penn Non-Invasive Cardiovascular Imaging
Penn Cardiothoracic Imaging
Search PubMed for articles
Penn Nuclear Medicine
Penn Non-Invasive Cardiovascular Imaging
Penn Cardiothoracic Imaging
Education:
MD (Doctor of Medicine)
Universidad del Valle, 2002.
Permanent linkMD (Doctor of Medicine)
Universidad del Valle, 2002.
Description of Clinical Expertise
Cardiac PET, myocardial blood flow quantification in ischemic and non-ischemic heart disease, myocardial inflammation, myocardial viability, cardiac magnetic resonance imaging, cardiomyopathies.Description of Research Expertise
I have a particular interest in the complementary role of radionuclide molecular imaging techniques and tissue characterization with contrast-enhanced cardiac magnetic resonance imaging for sub-clinical detection, phenotyping, diagnosis, and risk stratification of individuals with various forms of cardiomyopathy.Selected Publications
Bravo PE, Vita TS, Taqueti V, Veillet-Chowdhury M, Steigner M, Skali H, Dorbala S, Di Carli MF, Blankstein R. : Detection of Myocardial Inflammation by T2-weighted Imaging on Cardiac MRI versus FDG PET Among Patients with Suspected Cardiac Sarcoidosis. 22nd Annual Scientific Session of the American Society of Nuclear Cardiology Sept 2017 Notes: Poster PresentationBravo PE, Fujijura K, Kijewski MF, Jacob S, Sticka W, Dubey S, Belanger A, Park M, Di Carli MF, Falk RH, Dorbala S. : Apical Sparing of Longitudinal Strain Cannot be Explained by Regional Differences in Florbetapir Retention in Cardiac Amyloidosis. ASNC, 22nd Annual Scientific Session. 22nd Annual Scientific Session of the American Society of Nuclear Cardiology Sept 2017 Notes: Poster Presentation
Bravo PE, Raghu G, Rosenthal DG, Elman S, Petek BJ, Soine LA, Maki JH, Branch KR, Masri SC, Patton KK, Caldwell JH, Krieger EV: Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging. International Journal of Cardiology 15(241): 457-462, Aug 2017 Notes: DOI: 10.1016/j.ijcard.2017.03.033.
Gupta A, Taqueti VR, van de Hoef TP, Bajaj NS, Bravo PE, Murthy VL, Osborne MT, Seidelmann SB, Vita TS, Bibbo CF, Harrington M, Hainer J, Rimoldi O, Dorbala S, Bhatt DL, Blankstein R, Camici PG, Di Carli MF: Integrated Non-invasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients with Stable Coronary Artery Disease. Circulation 136(24): 2325-2336, Sept 2017 Notes: DOI: 10.1161/CIRCULATIONAHA.117.029992.
Bravo PE, Di Carli MF, Dorbala S: Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies. Heart Failure Reviews 22(4): 455-464, Jul 2017 Notes: DOI: 10.1007/s10741-017-9628-1.
Bravo PE, Dorbala S. : Targeted Nuclear Imaging Probes for Cardiac Amyloidosis. Current Cardiology Reports 19(7): 59, Jul 2017 Notes: DOI: 10.1007/s11886-017-0868-4.
Bravo PE, Taqueti VR: Cardiac MRI vs. PET for the Evaluation of Cardiac Sarcoidosis: Consider MRI First. American College of Cardiology Apr 2017 Notes: http://www.acc.org/latest-incardiology/articles/2017/04/10/08/43/cardiac-mri-vs-pet.
Bravo PE, Tahari A, Pozios I, Luo HC, Bengel FM, Wahl RL, Abraham MR, Abraham TP: Apparent Left Ventricular Cavity Dilatation during PET/CT in Hypertrophic Cardiomyopathy: Clinical Predictors and Potential Mechanisms. Journal of Nuclear Cardiology 23(6): 1304-1314, Dec 2016 Notes: DOI: 10.1007/s12350-015-0158-8.
Seidelmann SB, Claggett B, Bravo PE, Gupta A, Farhad H, Klein BE, Klein R, Di Carli MF, Solomon SD: Retinal Vessel Calibers in Predicting Longterm Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study. Circulation 134(18): 1328-1338, Nov 2016 Notes: DOI: 10.1161/CIRCULATIONAHA.116.023425.
Okada DR, Bravo PE, Vita T, Agarwal V, Osborne MT, Taqueti V, Skali H, Chareonthaitawee P, Dorbala S, Stewart G, Di Carli M, Blankstein R. : Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol 25(4): 1136-1146, Sept 2016 Notes: DOI: 10.1007/s12350-016-0658-1.